KYNTRA BIO INC (KYNB) Stock Cash Flow
NASDAQ:KYNB • US31572Q8814
Current stock price
7.05 USD
0 (0%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 183.45M | -47.58M | -284.23M | -293.65M | -290.02M | |||
| Depreciation Amortization | 748.00K | 2.69M | 9.93M | 10.60M | 14.81M | |||
| Change In Working Capital | -149.09M | -115.23M | -117.43M | 70.43M | 60.08M | |||
| Interest Paid | 7.83M | 16.21M | 54.00K | 100.00K | 90.00K | |||
| Other non cash items | -39.89M | 22.12M | 76.71M | 66.69M | 132.90M | |||
| OPERATING CASH FLOW | -4.77M | -138.00M | -315.02M | -145.93M | -82.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -38.00K | -266.00K | -2.52M | -38.74M | -30.19M | |||
| Other Investing Activity | 35.46M | 126.26M | 156.18M | 127.86M | -396.79M | |||
| INVESTING CASH FLOW | 35.42M | 125.99M | 153.66M | 89.12M | -426.97M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -80.56M | -40.00K | 70.85M | -540.00K | -5.89M | |||
| Stock Issued/Repurchased | 0.00 | 139.00K | 52.14M | 53.93M | 12.70M | |||
| Other Financing Activity | -5.47M | -354.00K | -237.00K | -6.62M | -7.37M | |||
| FINANCING CASH FLOW | -86.03M | -255.00K | 122.75M | 46.78M | -560.00K | |||
| Exchange Rate Effect | 1.08M | 751.00K | -3.40M | -5.48M | 2.60M | |||
| CHANGE IN CASH | -54.31M | -11.51M | -42.01M | -15.51M | -507.16M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.77M | -138.00M | -315.02M | -145.93M | -82.23M | |||
| Capital Expenditure | -38.00K | -266.00K | -2.52M | -38.74M | -30.19M | |||
| FREE CASH FLOW | -4.81M | -138.26M | -317.54M | -184.67M | -112.42M | |||
All data in USD